Literature DB >> 15499917

Development and evaluation of N-hydroxysuccinimide-activated silica for immobilizing human serum albumin in liquid chromatography columns.

Hee Seung Kim1, Young Sik Kye, David S Hage.   

Abstract

A method was developed for preparing N-hydroxysuccinimide (NHS)-activated silica for use in immobilizing human serum albumin (HSA) within HPLC columns. This support was made by reacting aminopropyl silica with disuccinimidyl suberate (DSS). Solid state 13C NMR was used to examine the steps in this synthesis. The number of NHS groups on the silica's surface was controlled by varying the amount of DSS or density of surface amine groups used in the preparing this material. Items considered in the use of this material for the immobilization of HSA included the amount of protein added to the support, the reaction time, and the pH of the coupling buffer. These supports were then evaluated in terms of their ability to perform chiral separations for R/S-warfarin and D/L-tryptophan. Advantages of this method compared to current immobilization techniques for HSA included its better long-term stability and the fact that it did not require the use of any reducing agents. The approaches developed in this work are not limited to HSA but can be used with other proteins or amine-containing ligands.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15499917

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  14 in total

1.  Development of sulfhydryl-reactive silica for protein immobilization in high-performance affinity chromatography.

Authors:  Rangan Mallik; Chunling Wa; David S Hage
Journal:  Anal Chem       Date:  2007-02-15       Impact factor: 6.986

2.  Rapid analysis of the interactions between drugs and human serum albumin (HSA) using high-performance affinity chromatography (HPAC).

Authors:  Hee Seung Kim; Irving W Wainer
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-05-24       Impact factor: 3.205

Review 3.  Affinity chromatography: A review of trends and developments over the past 50 years.

Authors:  Elliott L Rodriguez; Saumen Poddar; Sazia Iftekhar; Kyungah Suh; Ashley G Woolfork; Susan Ovbude; Allegra Pekarek; Morgan Walters; Shae Lott; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2020-08-14       Impact factor: 3.205

4.  Development of an affinity silica monolith containing alpha1-acid glycoprotein for chiral separations.

Authors:  Rangan Mallik; Hai Xuan; David S Hage
Journal:  J Chromatogr A       Date:  2007-03-25       Impact factor: 4.759

5.  Optimization of protein entrapment in affinity microcolumns using hydrazide-activated silica and glycogen as a capping agent.

Authors:  John Vargas-Badilla; Saumen Poddar; Shiden Azaria; Chenhua Zhang; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2019-05-04       Impact factor: 3.205

6.  Research in bioanalysis and separations at the University of Nebraska - Lincoln.

Authors:  David S Hage; Eric D Dodds; Liangcheng Du; Robert Powers
Journal:  Bioanalysis       Date:  2011-05       Impact factor: 2.681

7.  Development of an affinity silica monolith containing human serum albumin for chiral separations.

Authors:  Rangan Mallik; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2007-03-24       Impact factor: 3.935

8.  The preparation and development of cellular membrane affinity chromatography columns.

Authors:  Ruin Moaddel; Irving W Wainer
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

Review 9.  Analysis of biomolecular interactions using affinity microcolumns: a review.

Authors:  Xiwei Zheng; Zhao Li; Sandya Beeram; Maria Podariu; Ryan Matsuda; Erika L Pfaunmiller; Christopher J White; NaTasha Carter; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-01-27       Impact factor: 3.205

Review 10.  Characterization of drug-protein interactions in blood using high-performance affinity chromatography.

Authors:  David S Hage; Abby Jackson; Matthew R Sobansky; John E Schiel; Michelle J Yoo; K S Joseph
Journal:  J Sep Sci       Date:  2009-03       Impact factor: 3.645

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.